Zafgen Lands $33,000,000 Series C Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4457e7de-f132-4f30-9d70-dc17c8266a20&Preview=1 - Date
7/7/2011 - Company Name
Zafgen - Mailing Address
5 Cambridge Center Floor 2 Cambridge, MA 02142 - Company Description
The company is developing novel therapeutics for the treatment of obesity. - Website
http://www.zafgen.com - Transaction Type
Venture Equity - Transaction Amount
$33,000,000 - Transaction Round
Series C - Proceeds Purposes
Proceeds from the financing will be used to support development of Zafgen’s pipeline and to advance its lead methionine aminopeptidase 2 (MetAP2) inhibitor for the treatment of severe obesity into Phase 2 clinical studies. - M&A Terms
- Venture Investor
Atlas Venture - Venture Investor
Third Rock Ventures
